Research Article
FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome
Table 3
Clinical features of cases included in the study.
| Diagnostic group | Number of cases | M/F | Median age, years (range) | Follow-up (months) | Number of deaths (%)a |
| MF | 13 | 6/7 | 68 (35–86) | 87.3 (0.7–270.3) | 7 (54) | Patch | 4 | 3/1 | 69 (64–86) | 119.9 (12.3–157.9) | 1 (25) | Plaque | 4 | 1/3 | 69 (35–74) | 116.4 (27.5–155.1) | 3 (75) | Tumor | 5 | 2/3 | 63 (35–74) | 18.4 (0.7–270.3) | 3 (60) | E-CTCL | 13 | 7/6 | 69 (30–84) | 62.1 (0.8–244.8) | 8 (62) | E-MF | 1 | 1/0 | 67 | 185.3 | 0 (0) | SS | 7 | 4/3 | 71 (30–84) | 19.8 (0.8–62.1) | 7 (100) | NOS | 5 | 2/3 | 61 (45–83) | 127.6 (80.4–244.8) | 1 (20) | All cases | 26 | 13/13 | 68 (30–86) | 71.3 (0.7–270.3) | 15 (58) |
|
|
Death from disease-related cause. M: male; F: female; E: erythrodermic; CTCL: cutaneous T-cell lymphoma; MF: mycosis fungoides; SS: Sézary syndrome; NOS: not otherwise specified.
|